background image

Eczema Clinical Trials

Find clinical trials for eczema. Search for eczema clinical trials in different cities and states across the United States.

Filter
1

Dupilumab De-escalation in Pediatric Atopic Dermatitis

Recruiting

Sponsor:

Johns Hopkins University

Location:

Baltimore MD

Code:

NCT06116526

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

Dupilumab - Discontinuation

Dupilumab - Dose Reduction

Dupilumab - Standard Dose

The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis

Recruiting

Sponsor:

Phoilex Ltd.

Location:

Brampton

Code:

NCT06022874

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Phoilex Releaf Gel

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Recruiting

Sponsor:

Target PharmaSolutions, Inc.

Location:

Scottsdale AZ, Fort Smith AR, Little Rock AR, Fountain Valley CAshow 51 more

Code:

NCT03661866

Conditions

Atopic Dermatitis

Alopecia Areata

Hidradenitis Suppurativa

Vitiligo

Psoriasis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Recruiting
PHASE3

Sponsor:

Sanofi

Location:

Scottsdale AZ, Fountain Valley CA, Fremont CA, Lafayette CAshow 46 more

Code:

NCT06130566

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Recruiting
PHASE3

Sponsor:

LEO Pharma

Location:

Winnipeg, Windsor, Saskatoon, Niagara Fallsshow 14 more

Code:

NCT06311682

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 6 - 11

Healthy Volunteers: Not accepted

Interventions

Tralokinumab + TCS

Placebo + TCS

Cardamom and Topical Roseomonas in Atopic Dermatitis

Recruiting
PHASE2

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Bethesda MD

Code:

NCT06096857

Conditions

Atopic Dermatitis

Eczema

Eligibility Criteria

Sex: All

Age: 2 - 70+

Healthy Volunteers: Not accepted

Interventions

Roseomonas mucosa (RSM2015) and Cardamom seeds

Placebo (sucrose)

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Recruiting
PHASE3

Sponsor:

Sanofi

Location:

Birmingham AL, Fort Smith AR, Encino CA, Huntington Beach CAshow 45 more

Code:

NCT06224348

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Topical corticosteroids

Topical calcineurin inhibitors

Dupixent and Narrowband UVB for Atopic Dermatitis

Recruiting

Sponsor:

Psoriasis Treatment Center of Central New Jersey

Location:

East Windsor NJ

Code:

NCT05285839

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupixent

Bodewell Products for the Treatment of Atopic Dermatitis

Recruiting

Sponsor:

University of Alabama at Birmingham

Location:

Birmingham AL

Code:

NCT05566262

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bodewell Calming Cream

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Recruiting

Sponsor:

Sanofi

Location:

Denver CO, Saint Louis MO, New York NY

Code:

NCT05983068

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 6 - 14

Healthy Volunteers: Not accepted

Interventions

dupilumab